Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levofloxacin PK/PD in Healthy Volunteers
NCT02699658Phase 2
Key facts
- Status
- Completed
- Start
- Oct 2013
- Primary completion
- Aug 2014
- Countries
- 1
- Sponsor
- Prince of Songkla University
- Modality
- Small Molecules
- Drugs
- levofloxacin
- Conditions
- bacterial infection
01
Overview
Phase 2, open-label, single-arm trial of levofloxacin in bacterial infection, sponsored by Prince of Songkla University. Primary endpoint: concentration of levofloxacin in plasma up to 2 weeks. Started Oct 2013; status: completed.
02
Design
1 arm- Study design
- Non-randomizedOpen-labelSingle group
levofloxacin in healthy
Healthy volunteers receiving a single 500 mg dose of Levofloxacin.
03
Who it enrols
Healthy volunteers with normal hematologic, hepatic, and renal functions who are non-smoking, non-alcoholic, and non-obese.
04
Endpoints
Primary
concentration of levofloxacin in plasma
Beyond the preview
Go deeper on NCT02699658.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02699658.